We Deliver Results
Our company has developed innovative processes and safety protocols in order to deliver the highest cellular viability and safety standards. With these safety and quality standards, StemShot® and StemVive™ are poised to become the leaders of amniotic membrane allografts in the field of regenerative medicine and stem cell therapy. StemShot® and StemVive™ are morselized amniotic allograft flowables procured from the amniotic membrane, cord tissue and cord blood of non-aged placental tissues. StemShot® and StemVive™ are the first products to include these minimally manipulated material from membrane. We call this the Triple Threat. Both products are provided to physicians in a cryopreserved state that is ready for easy use.